FDA Inspection 1119027 — Millipore (U.K.) Ltd.

Millipore (U.K.) Ltd. — FEI 3002638287

The FDA completed an inspection of Millipore (U.K.) Ltd. on Feb 27, 2020 in Livingston. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 27, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston (United Kingdom)

Citations

IDCFRDescription
907821 CFR 600.12(a)Maintenance - tracing
932621 CFR 610.1Tests prior to release

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.